Loading clinical trials...
Loading clinical trials...
CTIMAP is a prospective multicenter observational study on patients with Mild Acute Biliary Pancreatitis (MABP) treated with Same Admission Cholecystectomy (SAC) and Interval Cholecystectomy (IC). The rationale of this study is to investigate the timing of cholecystectomy after MABP applied by Lombard surgeons and compare SAC and IC, with the hypothesis that SAC would reduce the risk of recurrent Gallstones Related Events (GRE) without increasing the difficulty of surgery and postoperative complications.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Fondazione IRCCS Policlinico San Matteo
Pavia, Pavia, Italy
Start Date
April 12, 2022
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2024
Last Updated
November 18, 2025
445
ACTUAL participants
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions